Skip to content

LAUNCHPAD EUROPE: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

LAUNCHPAD EUROPE

BE 0713.975.032
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€7,827
2024 · €5,834+€1,994
Equity
€42,343
2024 · €87,115-€44,773
Cash
€97,614
2024 · €128,545-€30,930
Balance sheet total
€120,635
2024 · €158,544-€37,909

Largest movements

2024 to 2025
Assets
  • Cash -€30,930

    down €30,930 (-24.1%), from €128,545 to €97,614

    mainly Contributions, distributions and other (-€52,600) and Accrued charges and deferred income (-€2,712)

  • Receivables within one year -€5,462

    down €5,462 (-25.0%), from €21,841 to €16,380

    of which Trade receivables: -€10,756

Equity and liabilities
  • Profit (loss) carried forward -€57,173

    down €57,173 (-72.3%), from €79,055 to €21,883

  • Contributions +€12,400

    up €12,400 (+200%), from €6,200 to €18,600

  • Trade debts +€6,143

    up €6,143 (+52.1%), from €11,797 to €17,940

  • Other debts +€3,749

    up €3,749 (+7.3%), from €51,501 to €55,250

  • Accrued charges and deferred income -€2,712

    down €2,712 (-48.3%), from €5,618 to €2,906

Income statement
  • Gross operating margin +€1,726

    up €1,726 (+20.0%), from €8,609 to €10,335

  • Financial income +€1,057

    up €1,057 (+853%), from €124 to €1,181

  • Other operating charges +€818

    up €818 (+649%), from €126 to €944

  • Taxes +€424

    up €424 (+19.4%), from €2,185 to €2,609

  • Financial charges -€273

    down €273 (-46.4%), from €589 to €316

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €5,834
Gross operating margin +€1,726
Write-downs +€180
Other operating charges -€818
Financial income +€1,057
Financial charges +€273
Taxes -€424
Result 2025 €7,827
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€21,659
Investment €0
Financing -€52,589
Cash 2024 €128,545
Net result for the year +€7,827
Stocks and contracts +€1,345
Receivables within one year +€5,462
Deferred charges and accrued income +€171
Trade debts +€6,143
Tax, wage and social debts -€328
Other debts +€3,749
Accrued charges and deferred income -€2,712
Short-term financial debts +€11
Contributions, distributions and other -€52,600
Cash 2025 €97,614
brings cash intakes cash out
Every line side by side 39 lines
Line Code 2024 2025 Change %
Total assets 20/58 €158,544 €120,635 -€37,909 -23.9%
Current assets 29/58 €158,544 €120,635 -€37,909 -23.9%
Stocks and contracts in progress 3 €7,987 €6,641 -€1,345 -16.8%
Stocks 30/36 €7,987 €6,641 -€1,345 -16.8%
Amounts receivable within one year 40/41 €21,841 €16,380 -€5,462 -25.0%
Trade receivables 40 €21,841 €11,085 -€10,756 -49.2%
Other amounts receivable 41 - €5,294 +€5,294
Cash at bank and in hand 54/58 €128,545 €97,614 -€30,930 -24.1%
Deferred charges and accrued income 490/1 €171 €0 -€171 -100%
Total equity and liabilities 10/49 €158,544 €120,635 -€37,909 -23.9%
Equity 10/15 €87,115 €42,343 -€44,773 -51.4%
Contributions 10/11 €6,200 €18,600 +€12,400 +200%
Reserves 13 €1,860 €1,860 = 0.0%
Non-distributable reserves 130/1 €1,860 €1,860 = 0.0%
Reserves not available under the articles 1311 €1,860 €1,860 = 0.0%
Profit (loss) carried forward 14 €79,055 €21,883 -€57,173 -72.3%
Amounts payable 17/49 €71,429 €78,292 +€6,863 +9.6%
Amounts payable within one year 42/48 €65,810 €75,386 +€9,576 +14.6%
Financial debts 43 €0 €11 +€11
Credit institutions 430/8 €0 €11 +€11
Trade debts 44 €11,797 €17,940 +€6,143 +52.1%
Suppliers 440/4 €11,797 €17,940 +€6,143 +52.1%
Taxes, remuneration and social security 45 €2,513 €2,185 -€328 -13.1%
Taxes 450/3 €2,513 €2,185 -€328 -13.1%
Other amounts payable 47/48 €51,501 €55,250 +€3,749 +7.3%
Accrued charges and deferred income 492/3 €5,618 €2,906 -€2,712 -48.3%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 - -€180 -€180
Provisions for liabilities and charges: additions (uses and reversals) 635/8 €0 - =
Other operating charges 640/8 €126 €944 +€818 +649%
Gross operating margin 9900 €8,609 €10,335 +€1,726 +20.0%
Operating profit (loss) 9901 €8,483 €9,571 +€1,088 +12.8%
Financial income 75/76B €124 €1,181 +€1,057 +853%
Recurring financial income 75 €124 €1,181 +€1,057 +853%
Financial charges 65/66B €589 €316 -€273 -46.4%
Recurring financial charges 65 €589 €316 -€273 -46.4%
Profit (loss) for the period before taxes 9903 €8,019 €10,437 +€2,418 +30.2%
Income taxes 67/77 €2,185 €2,609 +€424 +19.4%
Profit (loss) for the period 9904 €5,834 €7,827 +€1,994 +34.2%
Profit (loss) for the period to be appropriated 9905 €5,834 €7,827 +€1,994 +34.2%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 October 2026 via checked.be.